Literature DB >> 19189188

Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience.

Nikola Besic1, Janez Zgajnar, Marko Hocevar, Rok Petric.   

Abstract

BACKGROUND: No agreement has been made about the optimal extent of thyroidectomy or lymph node dissection in papillary thyroid microcarcinoma (PTMC). Our aim was to find out the factors associated with the presence of lymph node metastases in the patients with PTMC and to discuss the extent of thyroidectomy and lymphadenectomy.
METHODS: A total of 254 patients with PTMC (212 women, 42 men; age 14 to 85 years, median 47 years) were treated at our institute between 1975 and 2007. Lymph node metastases were confirmed in 59 patients (23%) by histopathology. The median observation time was 56 (range, 1-397) months, and the recurrence was diagnosed in seven patients. Modified radical neck dissection and central neck dissection were performed in 55 and 30 patients, respectively. The data on the clinicopathological characteristics of patients and treatment were collected.
RESULTS: An incidental PTMC was diagnosed in 107 patients postoperatively. In none of them was a lymph node metastasis or tumor recurrence detected. Preoperatively, an overt PTMC was diagnosed in 147 patients. Clinically manifest metastases were diagnosed in 59 (40%) of them: in 51 preoperatively, and in 8 during the surgical procedure. In 147 patients who had preoperative diagnosis of PTMC, the factors that correlated (P < 0.05) with the presence of lymph node metastases were sex, age, and tumor type.
CONCLUSIONS: The patients with high-risk PTMC with preoperatively confirmed lymph node metastases had a higher recurrence rate than those with low-risk PTMC without preoperatively detectable lymph node metastases; therefore, careful therapeutic node dissection is necessary in high-risk patients.

Entities:  

Mesh:

Year:  2009        PMID: 19189188     DOI: 10.1245/s10434-009-0332-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

Review 1.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

2.  Differentiated thyroid tumors: surgical indications.

Authors:  R Lucchini; M Monacelli; S Santoprete; R Triola; C Conti; R Pecoriello; P Favoriti; M S Di Patrizi; I Barillaro; A Boccolini; S Avenia; M D'Ajello; A Sanguinetti; N Avenia
Journal:  G Chir       Date:  2013 May-Jun

3.  Differences in the Form of Presentation between Papillary Microcarcinomas and Papillary Carcinomas of Larger Size.

Authors:  Carles Zafon; Juan Antonio Baena; Josep Castellví; Gabriel Obiols; Gabriela Monroy; Jordi Mesa
Journal:  J Thyroid Res       Date:  2010-12-14

Review 4.  Thyroid Papillary Microcarcinoma: Etiology, Clinical Manifestations,Diagnosis, Follow-up, Histopathology and Prognosis.

Authors:  Shiva Dideban; Alireza Abdollahi; Alipasha Meysamie; Shokouh Sedghi; Mona Shahriari
Journal:  Iran J Pathol       Date:  2016

5.  Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age.

Authors:  Jin-Kyu Cho; Ju-Yeon Kim; Chi-Young Jeong; Eun-Jung Jung; Soon-Tae Park; Sang-Ho Jeong; Young-Tae Ju; Young-Joon Lee; Soon-Chan Hong; Woo-Song Ha; Sang-Kyung Choi
Journal:  J Korean Surg Soc       Date:  2012-04-26

6.  Incidental Papillary Thyroid Microcarcinoma in an Endemic Goiter Area.

Authors:  Emin Gürleyik; Gunay Gurleyik; Banu Karapolat; Ufuk Onsal
Journal:  J Thyroid Res       Date:  2016-02-02

Review 7.  A meta-analysis on the effect of operation modes on the recurrence of papillary thyroid microcarcinoma.

Authors:  Dandan Yi; Peng Song; Tao Huang; Xiaoqiao Tang; Jianfeng Sang
Journal:  Oncotarget       Date:  2017-01-24

8.  Predicting non-small-volume central lymph node metastases (>5 or ≥2 mm) preoperatively in cN0 papillary thyroid microcarcinoma without extrathyroidal extension.

Authors:  Jin-Duo Shou; Fei-Bo Li; Liu-Hong Shi; Liang Zhou; Lei Xie; Jian-Biao Wang
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.